Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2013 | 10-2012 | 07-2012 | 04-2012 | 01-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 337 | 583 | 599 | 722 | 46 |
| Receivables | 318 | 112 | 90 | 70 | 25 |
| Inventories | 99 | 77 | 40 | 36 | 37 |
| TOTAL | $828 | $834 | $816 | $876 | $109 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 2 | 2 | 2 |
| TOTAL | $1 | $1 | $2 | $2 | $2 |
| Total Assets | $830 | $836 | $818 | $877 | $110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 180 |
| Accounts payable and accrued liabilities | 49 | 13 | 11 | 14 | 20 |
| Accrued Expenses | 1 | 14 | 1 | 1 | N/A |
| TOTAL | $51 | $72 | $24 | $21 | $204 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 83 |
| Deferred Revenues | 0 | 36 | N/A | N/A | N/A |
| TOTAL | $0 | $0 | $0 | $0 | $83 |
| Total Liabilities | $51 | $72 | $24 | $21 | $287 |
| Shareholders' Equity | |||||
| Retained earnings | -3,148 | -3,163 | -3,134 | -3,070 | -3,115 |
| Other shareholders' equity | 35 | 35 | 35 | 35 | 35 |
| TOTAL | $779 | $763 | $793 | $857 | $-176 |
| Total Liabilities And Equity | $830 | $836 | $818 | $877 | $110 |